Back to Search Start Over

LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC.

Authors :
Strickler, J.H.
Cercek, A.
Siena, S.
André, T.
Ng, K.
Van Cutsem, E.
Wu, C.
Paulson, A.S.
Hubbard, J.
Coveler, A.
Fountzilas, C.
Kardosh, A.
Kasi, P.M.
Lenz, H.J.
Ciombor, K.K.
Fernandez, M.E. Elez
Bajor, D.L.
Stecher, M.
Feng, W.
Bekaii-Saab, T.
Source :
Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1394-S1394. 1p.
Publication Year :
2022

Subjects

Subjects :
*TRASTUZUMAB
*MOUNTAINEERING
*MOUNTAINEERS

Details

Language :
English
ISSN :
09237534
Volume :
33
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
159078724
Full Text :
https://doi.org/10.1016/j.annonc.2022.08.023
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details